These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36807681)

  • 1. Slow conformational changes in the rigid and highly stable chymotrypsin inhibitor 2.
    Gavrilov Y; Prestel A; Lindorff-Larsen K; Teilum K
    Protein Sci; 2023 Apr; 32(4):e4604. PubMed ID: 36807681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double Mutant of Chymotrypsin Inhibitor 2 Stabilized through Increased Conformational Entropy.
    Gavrilov Y; Kümmerer F; Orioli S; Prestel A; Lindorff-Larsen K; Teilum K
    Biochemistry; 2022 Feb; 61(3):160-170. PubMed ID: 35019273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrophobic core mutations in CI2 globally perturb fast side-chain dynamics similarly without regard to position.
    Whitley MJ; Zhang J; Lee AL
    Biochemistry; 2008 Aug; 47(33):8566-76. PubMed ID: 18656953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain in the folding nucleus of chymotrypsin inhibitor 2.
    Ladurner AG; Itzhaki LS; Fersht AR
    Fold Des; 1997; 2(6):363-8. PubMed ID: 9427010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure of the transition state for folding of chymotrypsin inhibitor 2 analysed by protein engineering methods: evidence for a nucleation-condensation mechanism for protein folding.
    Itzhaki LS; Otzen DE; Fersht AR
    J Mol Biol; 1995 Nov; 254(2):260-88. PubMed ID: 7490748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Search for nucleation sites in smaller fragments of chymotrypsin inhibitor 2.
    Itzhaki LS; Neira JL; Ruiz-Sanz J; de Prat Gay G; Fersht AR
    J Mol Biol; 1995 Nov; 254(2):289-304. PubMed ID: 7490749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the protein folding transition state by mutation: Large scale (un)folding rate accelerations without altering native stability.
    Campos LA; Muñoz V
    Protein Sci; 2024 Jul; 33(7):e5031. PubMed ID: 38864692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards the complete structural characterization of a protein folding pathway: the structures of the denatured, transition and native states for the association/folding of two complementary fragments of cleaved chymotrypsin inhibitor 2. Direct evidence for a nucleation-condensation mechanism.
    Neira JL; Davis B; Ladurner AG; Buckle AM; Gay Gde P; Fersht AR
    Fold Des; 1996; 1(3):189-208. PubMed ID: 9079381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing invisible, low-populated States of protein molecules by relaxation dispersion NMR spectroscopy: an application to protein folding.
    Korzhnev DM; Kay LE
    Acc Chem Res; 2008 Mar; 41(3):442-51. PubMed ID: 18275162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folding of circular and permuted chymotrypsin inhibitor 2: retention of the folding nucleus.
    Otzen DE; Fersht AR
    Biochemistry; 1998 Jun; 37(22):8139-46. PubMed ID: 9609709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rate of isomerisation of peptidyl-proline bonds as a probe for interactions in the physiological denatured state of chymotrypsin inhibitor 2.
    Tan YJ; Oliveberg M; Otzen DE; Fersht AR
    J Mol Biol; 1997 Jun; 269(4):611-22. PubMed ID: 9217264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein folding from a highly disordered denatured state: the folding pathway of chymotrypsin inhibitor 2 at atomic resolution.
    Kazmirski SL; Wong KB; Freund SM; Tan YJ; Fersht AR; Daggett V
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4349-54. PubMed ID: 11274353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of rates of protein folding: the nucleation-condensation mechanism and its implications.
    Fersht AR
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10869-73. PubMed ID: 7479900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of an anomalously accelerating substitution in the folding of a prototypical two-state protein.
    Lawrence C; Kuge J; Ahmad K; Plaxco KW
    J Mol Biol; 2010 Oct; 403(3):446-58. PubMed ID: 20816985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of two-state to multi-state folding kinetics on fusion of two protein foldons.
    Inaba K; Kobayashi N; Fersht AR
    J Mol Biol; 2000 Sep; 302(1):219-33. PubMed ID: 10964571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilizing or Destabilizing: Simulations of Chymotrypsin Inhibitor 2 under Crowding Reveal Existence of a Crossover Temperature.
    Timr S; Sterpone F
    J Phys Chem Lett; 2021 Feb; 12(6):1741-1746. PubMed ID: 33570420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational Dynamics of a Cysteine-Stabilized Plant Defensin Reveals an Evolutionary Mechanism to Expose Hydrophobic Residues.
    Machado LESF; De Paula VS; Pustovalova Y; Bezsonova I; Valente AP; Korzhnev DM; Almeida FCL
    Biochemistry; 2018 Oct; 57(40):5797-5806. PubMed ID: 30207151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy between simulation and experiment in describing the energy landscape of protein folding.
    Ladurner AG; Itzhaki LS; Daggett V; Fersht AR
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8473-8. PubMed ID: 9671702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The changing nature of the protein folding transition state: implications for the shape of the free-energy profile for folding.
    Oliveberg M; Tan YJ; Silow M; Fersht AR
    J Mol Biol; 1998 Apr; 277(4):933-43. PubMed ID: 9545382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymer crowders and protein crowders act similarly on protein folding stability.
    Zhou HX
    FEBS Lett; 2013 Mar; 587(5):394-7. PubMed ID: 23353683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.